Skip To Main Content
OneThree Biotech on Muck Rack

OneThree Biotech

As seen in: Cell Press, Olean Times Herald
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with OneThree

Contact OneThree, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

OneThree Biotech Announces $2.5M Seed Funding & Free Toxicity Screening for Small Molecules Treating COVID-19

|
By OneThree Biotech
| Olean Times Herald Verified
NEW YORK, March 26, 2020 /PRNewswire/ -- OneThree Biotech, a biology-driven artificial intelligence platform that optimizes drug discovery and development, announces closing of a $2.5M seed round along with free toxicity screening to any academic or medical researcher working on developing a new drug to treat COVID-19.
Open in Who Shared Issue with article?

The Missing Pieces of Artificial Intelligence in Medicine

|
By Coryandar Gilvary, OneThree Biotech, Neel S. Madhukar, Jamal Elkhader
| Cell Press Verified
Highlights Deep neural networks have revolutionized the field of computer vision, which has subsequently led to advances in AI-driven dermatology, radiology, pathology, and many other fields of research. A number of different AI methods have shown promise when applied to bottlenecks in early-stage drug development – such as biomarker prediction and drug repurposing.
Open in Who Shared Issue with article?
See all 2 articles